Cargando…
The molecular mechanisms of Aloin induce gastric cancer cells apoptosis by targeting High Mobility Group Box 1
Purpose: Aloin (ALO), a bioactive ingredient extracted from aloe vera, has anti-tumor effects. High Mobility Group Box 1 (HMGB1), a highly conserved nuclear DNA-binding protein, has been implicated in various cancer types. Highly expressed HMGB1 is closely associated with tumor cells apoptosis, prol...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489572/ https://www.ncbi.nlm.nih.gov/pubmed/31114162 http://dx.doi.org/10.2147/DDDT.S201818 |
_version_ | 1783414845406707712 |
---|---|
author | Tao, Hong Tang, Tuo Wang, Shengnan Wang, Ziqian Ma, Yunfei Cai, Tianyu Cheng, Xiuliang Qi, Shimei Zhang, Yao Qi, Zhilin |
author_facet | Tao, Hong Tang, Tuo Wang, Shengnan Wang, Ziqian Ma, Yunfei Cai, Tianyu Cheng, Xiuliang Qi, Shimei Zhang, Yao Qi, Zhilin |
author_sort | Tao, Hong |
collection | PubMed |
description | Purpose: Aloin (ALO), a bioactive ingredient extracted from aloe vera, has anti-tumor effects. High Mobility Group Box 1 (HMGB1), a highly conserved nuclear DNA-binding protein, has been implicated in various cancer types. Highly expressed HMGB1 is closely associated with tumor cells apoptosis, proliferation and migration. We investigated the specific molecular mechanisms by which ALO-induced apoptosis by targeting HMGB1 in gastric cancer cells. Materials and methods: Human gastric cancer HGC-27 cells were treated with different doses of ALO (100, 200 and 400 µg/ml) for 24 h, after which DAPI staining was used to observe the nuclear morphology, Annexin V/PI double staining assay was used to determine the rate of apoptosis; Western blotting was used to detect the levels of PARP, pro-caspase3, HMGB1 and RAGE; nuclear translocation of HMGB1 was determined by conducting a nucleoplasm separation experiment. The Enzyme linked immunosorbent assay (ELISA) assay was used to detect release of HMGB1. The HGC-27 cells, transfected with HMGB1 shRNA plasmids, were stimulated with ALO for 24 h, after which a flow cytometry assay was used to detect the rate of apoptosis. HGC-27 cells were pre-treated with or without ALO and then stimulated with rhHMGB1, the phosphorylation of Akt, mTOR, P70S6K, S6, 4EBP1, ERK, P90RSK, cAMP regulatory element binding (CREB) were detected by Western blotting. Results: After different doses of ALO treatment, the nuclei showed morphological changes characteristic of apoptosis. Apoptotic rates were enhanced in a dose dependent manner. The level of cleaved PARP was enhanced and pro-caspase3, HMGB1 and RAGE levels were reduced, HMGB1 nuclear translocation and release were inhibited. The activation of rhHMGB1-induced Akt-mTOR-P70S6K and ERK-CREB signalling pathways was inhibited by ALO. Blocking these signalling pathways by special inhibitors and HMGB1 knockdown could enhance ALO-induced HGC-27 cell apoptosis. Conclusion: ALO- induced HGC-27 cell apoptosis by down-regulating expressions of HMGB1 and RAGE, inhibiting HMGB1 release and then suppressing rhHMGB1-induced activation of Akt-mTOR-P70S6K and ERK-P90RSK-CREB signalling pathways. |
format | Online Article Text |
id | pubmed-6489572 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-64895722019-05-21 The molecular mechanisms of Aloin induce gastric cancer cells apoptosis by targeting High Mobility Group Box 1 Tao, Hong Tang, Tuo Wang, Shengnan Wang, Ziqian Ma, Yunfei Cai, Tianyu Cheng, Xiuliang Qi, Shimei Zhang, Yao Qi, Zhilin Drug Des Devel Ther Original Research Purpose: Aloin (ALO), a bioactive ingredient extracted from aloe vera, has anti-tumor effects. High Mobility Group Box 1 (HMGB1), a highly conserved nuclear DNA-binding protein, has been implicated in various cancer types. Highly expressed HMGB1 is closely associated with tumor cells apoptosis, proliferation and migration. We investigated the specific molecular mechanisms by which ALO-induced apoptosis by targeting HMGB1 in gastric cancer cells. Materials and methods: Human gastric cancer HGC-27 cells were treated with different doses of ALO (100, 200 and 400 µg/ml) for 24 h, after which DAPI staining was used to observe the nuclear morphology, Annexin V/PI double staining assay was used to determine the rate of apoptosis; Western blotting was used to detect the levels of PARP, pro-caspase3, HMGB1 and RAGE; nuclear translocation of HMGB1 was determined by conducting a nucleoplasm separation experiment. The Enzyme linked immunosorbent assay (ELISA) assay was used to detect release of HMGB1. The HGC-27 cells, transfected with HMGB1 shRNA plasmids, were stimulated with ALO for 24 h, after which a flow cytometry assay was used to detect the rate of apoptosis. HGC-27 cells were pre-treated with or without ALO and then stimulated with rhHMGB1, the phosphorylation of Akt, mTOR, P70S6K, S6, 4EBP1, ERK, P90RSK, cAMP regulatory element binding (CREB) were detected by Western blotting. Results: After different doses of ALO treatment, the nuclei showed morphological changes characteristic of apoptosis. Apoptotic rates were enhanced in a dose dependent manner. The level of cleaved PARP was enhanced and pro-caspase3, HMGB1 and RAGE levels were reduced, HMGB1 nuclear translocation and release were inhibited. The activation of rhHMGB1-induced Akt-mTOR-P70S6K and ERK-CREB signalling pathways was inhibited by ALO. Blocking these signalling pathways by special inhibitors and HMGB1 knockdown could enhance ALO-induced HGC-27 cell apoptosis. Conclusion: ALO- induced HGC-27 cell apoptosis by down-regulating expressions of HMGB1 and RAGE, inhibiting HMGB1 release and then suppressing rhHMGB1-induced activation of Akt-mTOR-P70S6K and ERK-P90RSK-CREB signalling pathways. Dove 2019-04-17 /pmc/articles/PMC6489572/ /pubmed/31114162 http://dx.doi.org/10.2147/DDDT.S201818 Text en © 2019 Tao et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Tao, Hong Tang, Tuo Wang, Shengnan Wang, Ziqian Ma, Yunfei Cai, Tianyu Cheng, Xiuliang Qi, Shimei Zhang, Yao Qi, Zhilin The molecular mechanisms of Aloin induce gastric cancer cells apoptosis by targeting High Mobility Group Box 1 |
title | The molecular mechanisms of Aloin induce gastric cancer cells apoptosis by targeting High Mobility Group Box 1 |
title_full | The molecular mechanisms of Aloin induce gastric cancer cells apoptosis by targeting High Mobility Group Box 1 |
title_fullStr | The molecular mechanisms of Aloin induce gastric cancer cells apoptosis by targeting High Mobility Group Box 1 |
title_full_unstemmed | The molecular mechanisms of Aloin induce gastric cancer cells apoptosis by targeting High Mobility Group Box 1 |
title_short | The molecular mechanisms of Aloin induce gastric cancer cells apoptosis by targeting High Mobility Group Box 1 |
title_sort | molecular mechanisms of aloin induce gastric cancer cells apoptosis by targeting high mobility group box 1 |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489572/ https://www.ncbi.nlm.nih.gov/pubmed/31114162 http://dx.doi.org/10.2147/DDDT.S201818 |
work_keys_str_mv | AT taohong themolecularmechanismsofaloininducegastriccancercellsapoptosisbytargetinghighmobilitygroupbox1 AT tangtuo themolecularmechanismsofaloininducegastriccancercellsapoptosisbytargetinghighmobilitygroupbox1 AT wangshengnan themolecularmechanismsofaloininducegastriccancercellsapoptosisbytargetinghighmobilitygroupbox1 AT wangziqian themolecularmechanismsofaloininducegastriccancercellsapoptosisbytargetinghighmobilitygroupbox1 AT mayunfei themolecularmechanismsofaloininducegastriccancercellsapoptosisbytargetinghighmobilitygroupbox1 AT caitianyu themolecularmechanismsofaloininducegastriccancercellsapoptosisbytargetinghighmobilitygroupbox1 AT chengxiuliang themolecularmechanismsofaloininducegastriccancercellsapoptosisbytargetinghighmobilitygroupbox1 AT qishimei themolecularmechanismsofaloininducegastriccancercellsapoptosisbytargetinghighmobilitygroupbox1 AT zhangyao themolecularmechanismsofaloininducegastriccancercellsapoptosisbytargetinghighmobilitygroupbox1 AT qizhilin themolecularmechanismsofaloininducegastriccancercellsapoptosisbytargetinghighmobilitygroupbox1 AT taohong molecularmechanismsofaloininducegastriccancercellsapoptosisbytargetinghighmobilitygroupbox1 AT tangtuo molecularmechanismsofaloininducegastriccancercellsapoptosisbytargetinghighmobilitygroupbox1 AT wangshengnan molecularmechanismsofaloininducegastriccancercellsapoptosisbytargetinghighmobilitygroupbox1 AT wangziqian molecularmechanismsofaloininducegastriccancercellsapoptosisbytargetinghighmobilitygroupbox1 AT mayunfei molecularmechanismsofaloininducegastriccancercellsapoptosisbytargetinghighmobilitygroupbox1 AT caitianyu molecularmechanismsofaloininducegastriccancercellsapoptosisbytargetinghighmobilitygroupbox1 AT chengxiuliang molecularmechanismsofaloininducegastriccancercellsapoptosisbytargetinghighmobilitygroupbox1 AT qishimei molecularmechanismsofaloininducegastriccancercellsapoptosisbytargetinghighmobilitygroupbox1 AT zhangyao molecularmechanismsofaloininducegastriccancercellsapoptosisbytargetinghighmobilitygroupbox1 AT qizhilin molecularmechanismsofaloininducegastriccancercellsapoptosisbytargetinghighmobilitygroupbox1 |